Starling Oncology, Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
Starling Oncology, Inc. (DFPH) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $0 as of 2024-06-30, per its 10-Q filed 2024-08-13.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2025-03-26
- 2024-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2024-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2023-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $5.00K.
- 2023-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2023-12-31 | $5.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $6.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $13.00K 10-Q · filed 2022-11-09 |